The National Biotechnology Development Agency, NABDA, has identified three drugs to be used for the treatment and eradication of Lassa fever.
Director-General of NABDA, Abdullahi Mustapha, revealed that scientists at the Genetics, Genomics and Bioinformatics Department of the agency, in collaboration with other researchers organized the research.
Mustapha expressed optimism that the drugs would address the challenges faced in treating patients diagnosed with Lassa fever ailment.
The Director-General added that the challenge was to intensify surveillance and response by ensuring the availability of diagnostic centers across most affected regions.